Lalu, A. C., Kundil, V. T., Ben, J. B., R, D. R., Amritha, T., Suhail, S., . . . Abhithaj, J. (2025). Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach. Viruses. https://doi.org/10.3390/v17121613
Panoya başarıyla kopyalandı
Panoya kopyalama başarısız oldu
Chicago Style (17. basım) Atıf
Lalu, Anjana C., Varun Thachan Kundil, Joseph Bristow Ben, Dev Radul R, Thaikkad Amritha, Subair Suhail, Raju Rajesh, ve Jayanandan Abhithaj. "Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach."
Viruses 2025. https://doi.org/10.3390/v17121613.
Panoya başarıyla kopyalandı
Panoya kopyalama başarısız oldu
MLA (9th ed.) Atıf
Lalu, Anjana C., et al. "Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach."
Viruses, 2025, https://doi.org/10.3390/v17121613.
Panoya başarıyla kopyalandı
Panoya kopyalama başarısız oldu
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..